Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency

Clinical and Experimental Immunology

Volumn 161, Issue 1, 2010, Pages 48-56

  Akesson C ^a   Uvebrant, K ^a   Oderup, C ^a,g   Lynch, K ^c   Harris, R A ^e   Lernmark, A ^c   Agardh, C D ^b   Cilio, C M ^a,d,f  

^a Cellular Autoimmunity Unit

^b Diabetes and Metabolism Unit   (United States)

^c Department of Clinical Sciences ^*

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f LUND UNIVERSITY   (Sweden)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune; KIR3DL1; LADA; NK cells; NKG2D

Indexed keywords

GLUTAMATE DECARBOXYLASE 65 ANTIBODY; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL KILLER CELL RECEPTOR NKG2D;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETOGENESIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INSULIN DEFICIENCY; LATENT AUTOIMMUNE DIABETES IN ADULTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGE OF ONSET; AGED; AUTOANTIBODIES; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INSULIN; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PREDIABETIC STATE; RECEPTORS, KIR3DL1; RISK; T-LYMPHOCYTE SUBSETS;

EID: 77953280169     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04114.x     Document Type: Article

References (51)

1. McDevitt HO, Unanue ER. Autoimmune diabetes mellitus - much progress, but many challenges. Adv Immunol 2008 100:1 12.
2. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993 42:359 362.
3. Irvine WJ, McCallum CJ, Gray RS, Duncan LJ. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1977 1:1025 1027.
4. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986 35:237 241.
5. Hagopian WA, Karlsen AE, Gottsater A et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993 91:368 374.
6. Zimmet PZ, Tuomi T, Mackay IR et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994 11:299 303.
7. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995 18:1557 1565.
8. Turner R, Stratton I, Horton V et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997 350:1288 1293.
9. Tuomi T, Carlsson A, Li H et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 48:150 157.
10. Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 2000 85:76 80.
11. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003 3:413 425.
12. Baxter AG, Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity 2002 35:1 14.
13. Johansson S, Berg L, Hall H, Hoglund P. NK cells: elusive players in autoimmunity. Trends Immunol 2005 26:613 618.
14. Lanier LL. Activating and inhibitory NK cell receptors. Adv Exp Med Biol 1998 452:13 18.
15. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999 17:875 904.
16. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003 3:304 316.
17. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005 5:201 214.
18. Lopez-Larrea C, Suarez-Alvarez B, Lopez-Soto A, Lopez-Vazquez A, Gonzalez S. The NKG2D receptor: sensing stressed cells. Trends Mol Med 2008 14:179 189.
19. Zhang C, Zhang J, Tian ZG. The regulatory effect of natural killer cells: do 'NK-reg cells' exist? Cell Mol Immunol 2006 3:241 254.
20. Negishi K, Waldeck N, Chandy G et al. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes. Diabetologia 1986 29:352 357.
21. Nair MP, Lewis EW, Schwartz SA. Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities. J Clin Immunol 1986 6:363 372.
22. Hussain MJ, Alviggi L, Millward BA, Leslie RD, Pyke DA, Vergani D. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined. Diabetologia 1987 30:907 911.
23. Herold KC, Huen A, Gould L, Traisman H, Rubenstein AH. Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia 1984 27 (Suppl. 102 105.
24. Scheinin T, Maenpaa J, Kontiainen S. Immune responses to insulin and lymphocyte subclasses at diagnosis of insulin-dependent diabetes and one year later. Immunobiology 1990 180:431 440.
25. Wilson RG, Anderson J, Shenton BK, White MD, Taylor RM, Proud G. Natural killer cells in insulin dependent diabetes mellitus. BMJ (Clin Res Ed) 1986 293:244.
26. Lorini R, Moretta A, Valtorta A et al. Cytotoxic activity in children with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1994 23:37 42.
27. Rodacki M, Svoren B, Butty V et al. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007 56:177 185.
28. Schranz DB, Bekris L, Landin-Olsson M et al. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). J Immunol Methods 1998 213:87 97.
29. Grubin CE, Daniels T, Toivola B et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994 37:344 350.
30. Ilonen J, Reijonen H, Herva E et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1996 19:795 800.
31. Sjoroos M, Iitia A, Ilonen J, Reijonen H, Lovgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 1995 18:870 877.
32. Steffens-Nakken HM, Zwart G, van den Bergh FA. Validation of allele-specific polymerase chain reaction for DNA typing of HLA-B27. Clin Chem 1995 41:687 692.
33. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995 181:1133 1144.
34. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001 167:1245 1253.
35. Horwitz DA, Gray JD, Ohtsuka K, Hirokawa M, Takahashi T. The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. Immunol Today 1997 18:538 542.
36. Kos FJ. Regulation of adaptive immunity by natural killer cells. Immunol Res 1998 17:303 312.
37. Ogasawara K, Hamerman JA, Hsin H et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003 18:41 51.
38. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994 180:537 543.
39. Gumperz JE, Parham P. The enigma of the natural killer cell. Nature 1995 378:245 248.
40. Terme M, Chaput N, Combadiere B et al. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol 2008 180:4679 4686.
41. Giroux M, Yurchenko E, St-Pierre J et al. T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex. J Immunol 2007 179:4492 4502.
42. Zimmer J, Andres E, Hentges F. NK cells and Treg cells: a fascinating dance cheek to cheek. Eur J Immunol 2008 38:2942 2945.
43. Ghiringhelli F, Menard C, Terme M et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005 202:1075 1085.
44. Smyth MJ, Teng MW, Swann J et al. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006 176:1582 1587.
45. Barao I, Hanash AM, Hallett W et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006 103:5460 5465.
46. Trzonkowski P, Szmit E, Mysliwska J et al. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 2004 112:258 267.
47. Romagnani C, Della Chiesa M, Kohler S et al. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 2005 35:2452 2458.
48. Nishikawa H, Kato T, Tawara I et al. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA 2005 102:9253 9257.
49. Vivier E, Tomasello E, Baratin M et al. Functions of natural killer cells. Nat Immunol 2008 9:503 510.
50. Brillard E, Pallandre JR, Chalmers D et al. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Exp Hematol 2007 35:416 425.
51. Roy S, Barnes PF, Garg A et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008 180:1729 1736.